Affas Besse News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Affas besse. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Affas Besse Today - Breaking & Trending Today

LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections

SCHLIEREN, Switzerland, October 09, 2023 LimmaTech Biologics AG today announced the closing of a USD 37 million (CHF 33 million) Series A financing round co-led by Adjuvant Capital, AXA IM Alts, and the Novo Holdings REPAIR Impact Fund. The proceeds will enable LimmaTech to advance its proprietary technology platform and accelerate its pipeline of preclinical and clinical vaccine candidates against increasingly dangerous bacterial infections, including programs addressing shigellosis and gonorr ....

United States , New York , City Of , United Kingdom , Alexander Siebert , Kabeer Aziz , Zina Affas Besse , Limmatech Biologics , Franz Werner Haas , Camilla Petrycer Hansen , Hooft Van Huijsduijnen , Limmatech Bio , Novo Holding , Principal At Novo Holdings , Impact Fund , National Overview , Infective Resistance Impact Fund , Novo Holdings , Novo Nordisk Foundation , World Health Organization , Trophic Communications , United States Centers For Disease , Adjuvant Capital , Affas Besse , Deputy Head , Private Equity ,

LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidru

SCHLIEREN, Switzerland (BUSINESS WIRE) LimmaTech Biologics AG today announced the closing of a USD 37 million (CHF 33 million) Series A financing round co-led by Adjuvant Capital, AXA IM Alts, and the Novo Holdings REPAIR Impact Fund. The proceeds will enable LimmaTech to advance its proprietary technology platfor. ....

United States , New York , City Of , United Kingdom , Zina Affas Besse , Camilla Petrycer Hansen , Kabeer Aziz , Limmatech Bio , Alexander Siebert , Hooft Van Huijsduijnen , Franz Werner Haas , Limmatech Biologics , Trophic Communications , Novo Holdings , Novo Holding , National Overview , United States Centers For Disease , World Health Organization , Impact Fund , Principal At Novo Holdings , Novo Nordisk Foundation , Infective Resistance Impact Fund , Adjuvant Capital , Affas Besse , Deputy Head , Private Equity ,

LimmaTech Biologics AG: LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections

LimmaTech Biologics AG: LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , New York , City Of , United Kingdom , Zina Affas Besse , Hooft Van Huijsduijnen , Camilla Petrycer Hansen , Alexander Siebert , Franz Werner Haas , Limmatech Bio , Limmatech Biologics , Kabeer Aziz , Novo Holdings , Trophic Communications , Novo Nordisk Foundation , United States Centers For Disease , World Health Organization , Impact Fund Home , Novo Holding , National Overview , Infective Resistance Impact Fund , Impact Fund , Principal At Novo Holdings , Adjuvant Capital , Affas Besse , Deputy Head ,

Eyenuk Announces $6.2 Million Financing to Accelerate Adoption of FDA-cleared AI Technology for Detection of Diabetic Retinopathy

Eyenuk Announces $6.2 Million Financing to Accelerate Adoption of FDA-cleared AI Technology for Detection of Diabetic Retinopathy
Font : A-A+
LOS ANGELES, July 20, 2021 (GLOBE NEWSWIRE) Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening, today announced that it has completed a financing round of US$6.2 million led by AXA IM, through AXA IM Alts, a global leader in alternative investments with c. 162 billion of assets under management
1. Eyenuks existing investors also participated in the round.
Eyenuk will use the proceeds to immediately accelerate commercialization of the EyeArt ....

United States , Zina Affas Besse , Frank Cheng , Asia Pacific , Affas Besse , Kaushal Solanki , Global Health Investment Fund , Partner At Global Health Investment Advisors , Us National Institutes Of Health , Health Insurance Portability , Uk National Health Service , Global Health Investment Advisors , European Union , Eyenuk Inc , Health Canada , Managing Partner , Jonathan Dean , Impact Investing , Health Service , General Data Protection Regulation , Accountability Act , Current Procedural Terminology , Autonomous Detection , North America , ஒன்றுபட்டது மாநிலங்களில் , ஸீந ஆகாஸ் பெஸ்ஸி ,

Eyenuk, Inc.: Eyenuk Announces $6.2 Million Financing to Accelerate Adoption of FDA-cleared AI Technology for Detection of Diabetic Retinopathy

Eyenuk, Inc.: Eyenuk Announces $6.2 Million Financing to Accelerate Adoption of FDA-cleared AI Technology for Detection of Diabetic Retinopathy
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Zina Affas Besse , Frank Cheng , Asia Pacific , Affas Besse , Kaushal Solanki , Global Health Investment Fund , Partner At Global Health Investment Advisors , Us National Institutes Of Health , Health Insurance Portability , Uk National Health Service , Global Health Investment Advisors , European Union , Eyenuk Inc , Health Canada , Managing Partner , Jonathan Dean , Impact Investing , Health Service , General Data Protection Regulation , Accountability Act , Current Procedural Terminology , Autonomous Detection , North America , ஒன்றுபட்டது மாநிலங்களில் , ஸீந ஆகாஸ் பெஸ்ஸி ,